Anoop P. Patel

Medicine · Health Sciences

31h-index18.9kcitations125works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(38), Single-cell and spatial transcriptomics(37), Cancer Genomics and Diagnostics(19), Epigenetics and DNA Methylation(11), Cancer Cells and Metastasis(9)

Publications120 total

Supplementary Table 2 from Upregulation of TNFR2 Precedes TOX Expression by Exhausted T cells and Restricts Antitumor and Antiviral Immunity
2026Open Access
Supplementary Table 3 from Upregulation of TNFR2 Precedes TOX Expression by Exhausted T cells and Restricts Antitumor and Antiviral Immunity
2026Open Access
Supplementary Figures 1-8 from Upregulation of TNFR2 Precedes TOX Expression by Exhausted T cells and Restricts Antitumor and Antiviral Immunity
2026Open Access
Upregulation of TNFR2 Precedes TOX Expression by Exhausted T cells and Restricts Antitumor and Antiviral Immunity
Clinical Cancer Research·2025· 1 citedOpen Access
IMMU-74. Novel screening method to identify potent immune-inspired inhibitors for NOT-gated CAR T cells to suppress on-target-off-tumor toxicity in brain tumors
Neuro-Oncology·2025Open Access
IMMU-81. Glioblastoma and other intracranial pathologies elicit systemic sympathetic hyperactivity that limits immunotherapeutic responses
Neuro-Oncology·2025Open Access
EXTH-68. Targeting Tumor Heterogeneity And Plasticity in Glioblastoma With Novel CAR T Cells Targeting PTPRZ1
Neuro-Oncology·2025Open Access
EXTH-66. Logic-Guided Antigen Pairing and TEV-Responsive CAR Designs for Precision Immunotherapy in Glioblastoma
Neuro-Oncology·2025Open Access
IMMU-52. Novel Insights into T cell Exhaustion in GBM and other Solid Tumors
Neuro-Oncology·2025Open Access
A surgical window of opportunity trial evaluating the effect of the PCSK9 inhibitor evolocumab on tumoral MHC-I expression and CD8+ infiltration in glioma
Scientific Reports·2025· 1 citedOpen Access
Characterization of quiescent subpopulations and proliferative compartments in glioblastoma
2025Open Access
KS03.4.A SPATIAL MULTI-OMIC PROFILING REVEALS DETERMINANTS OF TIL EXPANDABILITY IN HIGH-GRADE GLIOMAS
Neuro-Oncology·2025Open Access
KS01.6.A INTRATUMORAL IL-12/ANTI-PD-1 ONCOLYTIC HSV1 (MVR-C5252) IS SAFE AND IMMUNOACTIVE IN RECURRENT HIGH-GRADE GLIOMA: PRELIMINARY PHASE 1 RESULTS FROM A MULTICENTER MULTISTAGE CLINICAL TRIAL
Neuro-Oncology·2025Open Access
HCN channels reveal conserved and divergent physiology in supragranular pyramidal neurons in primate species
2025· 1 citedOpen Access
DSAI-01 ENHANCING CAR T CELL SPECIFICITY IN LUNG CANCER BRAIN METASTASES THROUGH LOGIC-GATED TARGET DISCOVERY USING SINGLE-CELL TRANSCRIPTOMICS
Neuro-Oncology Advances·2025Open Access
IL-12 Secreting CAR-T Cells Reprogram the Tumor Microenvironment and Improve Efficacy Against Heterogeneous Models of Glioblastoma
2025· 1 citedOpen Access
KAT5 regulates neurodevelopmental states associated with G0-like populations in glioblastoma
Nature Communications·2025· 3 citedOpen Access
A Spatial Multi-Omic Framework Identifies Gliomas Permissive to TIL Expansion
2025Open Access
Abstract CT056: A phase 1 study of intratumoral HSV1 co-expressing IL-12 and PD1 blocking antibody (MVR-C5252) in recurrent high-grade glioma
Cancer Research·2025· 1 cited
Abstract 3193: Overcoming glioblastoma heterogeneity and plasticity through the development of novel chimeric antigen receptor (CAR)-T cells targeting PTPRZ1
Cancer Research·2025
page 1 of 6Next →

Frequent Co-authors

B Bernstein(11), William T. Curry(10), Hiroaki Wakimoto(10), Mario L. Suvà(10), Shawn Gillespie(9), C. Dirk Keene(9), Richard G. Ellenbogen(8), David N. Louis(8), Itay Tirosh(8), Brian V. Nahed(7), Orit Rozenblatt–Rosen(7), Daniel P. Cahill(7), Charles Cobbs(7), Aviv Regev(6), Miguel N. Rivera(6), Patrick J. Cimino(6), Christopher Rodman(5), Ravindra Mylvaganam(5), Andrew S. Venteicher(5), Robert L. Martuza(5)